Evernorth’s Accredo Earns URAC Rare Disease Pharmacy Center of Excellence Designation
BLOOMFIELD, Conn., February 10, 2022 – Accredo, the specialty pharmacy subsidiary of Evernorth, the health service of Cigna Corporation, was awarded URAC’s Rare Disease Pharmacy Center of Excellence designation. The URAC accreditation recognizes Accredo for demonstrating a commitment to quality health services, patient safety and improved outcomes for patients with rare diseases.
“The patients we serve have the most complex health problems and they deserve the highest quality of specialized care,” said Matt Perlberg, president, pharmacy companies, Evernorth. “This accreditation is an important indicator of excellence and reflects our continued focus on improving health outcomes for patients with rare diseases.”
An estimated 25 to 30 million people in the US suffer from a rare disease and about two-thirds are children. Accredo’s Rare Disease Therapeutic Resource Center provides specialized pharmacy and clinical home care to patients with 23 different rare diseases. The company’s healthcare team consists of approximately 500 specialty pharmacists and 600 field nurses, as well as social workers and dieticians. Accredo has already earned the URAC Specialty Pharmacy Accreditation, effective January 1, 2024.
“Now more than ever, pharmacies and related pharmaceutical services play a critical role in the healthcare system. Given the complicated nature of chronic diseases, pharmacies like Accredo do much more than just fill a prescription. As trusted experts on the front lines of healthcare delivery, they often provide targeted patient support and education to ensure proper medication management,” said URAC President and CEO Shawn Griffin, MD. long-term commitment to ensure patient safety and improve outcomes.”
Evernorth creates and connects world-class health services, including benefits management, pharmacy, healthcare solutions, insights and information. With an open approach to collaboration across the healthcare landscape, we deliver innovative and flexible solutions for health plans, employers and government programs. Evernorth’s capabilities are powered by our family of companies including Express Scripts, Express Scripts Pharmacy, Accredo, eviCore and MDLIVE, along with holistic Evernorth platforms and solutions that improve health and drive progress for people and businesses. All Evernorth solutions are maintained and delivered by or through operating subsidiaries of Evernorth Health, a wholly owned subsidiary of Cigna Corporation (NYSE: CI), or third-party partners. Learn more at Evernorth.com.
Founded in 1990 as a non-profit organization, URAC is the independent leader in advancing healthcare quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide range of stakeholders and industry experts. The company’s portfolio of accreditation and certification programs spans the healthcare industry and includes healthcare management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to demonstrate their validated commitment to quality and accountability.